Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes

The increase in and concern about neurodegenerative diseases continue to grow in an increasingly long-lived world population. Therefore, the search for new drugs continues to be a priority for medicinal chemistry. We present here the synthesis of a series of compounds with acetamide nuclei. Their st...

Full description

Autores:
Camargo-Ayala, Lorena
Bedoya, Mauricio
Prent-Peñaloza, Luis
Polo-Cuadrado, Efraín
Osorio Lopez, Edison Humberto
Brito, Iván
Delgado, Gerzon E.
González, Wendy
Gutierrez, Margarita
Tipo de recurso:
Article of investigation
Fecha de publicación:
2024
Institución:
Universidad de Ibagué
Repositorio:
Repositorio Universidad de Ibagué
Idioma:
eng
OAI Identifier:
oai:repositorio.unibague.edu.co:20.500.12313/5800
Acceso en línea:
https://hdl.handle.net/20.500.12313/5800
https://pubs.rsc.org/en/content/articlelanding/2024/ra/d3ra08649f
Palabra clave:
Estructura cristalina
Binding energy
Crystal structure
Free energy
Neurodegenerative diseases
Quantum chemistry
Rights
openAccess
License
© 2024 The Royal Society of Chemistry.
id UNIBAGUE2_b8eaa012a5d31a7450f7f67a70177819
oai_identifier_str oai:repositorio.unibague.edu.co:20.500.12313/5800
network_acronym_str UNIBAGUE2
network_name_str Repositorio Universidad de Ibagué
repository_id_str
dc.title.eng.fl_str_mv Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes
title Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes
spellingShingle Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes
Estructura cristalina
Binding energy
Crystal structure
Free energy
Neurodegenerative diseases
Quantum chemistry
title_short Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes
title_full Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes
title_fullStr Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes
title_full_unstemmed Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes
title_sort Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes
dc.creator.fl_str_mv Camargo-Ayala, Lorena
Bedoya, Mauricio
Prent-Peñaloza, Luis
Polo-Cuadrado, Efraín
Osorio Lopez, Edison Humberto
Brito, Iván
Delgado, Gerzon E.
González, Wendy
Gutierrez, Margarita
dc.contributor.author.none.fl_str_mv Camargo-Ayala, Lorena
Bedoya, Mauricio
Prent-Peñaloza, Luis
Polo-Cuadrado, Efraín
Osorio Lopez, Edison Humberto
Brito, Iván
Delgado, Gerzon E.
González, Wendy
Gutierrez, Margarita
dc.subject.armarc.none.fl_str_mv Estructura cristalina
topic Estructura cristalina
Binding energy
Crystal structure
Free energy
Neurodegenerative diseases
Quantum chemistry
dc.subject.proposal.eng.fl_str_mv Binding energy
Crystal structure
Free energy
Neurodegenerative diseases
Quantum chemistry
description The increase in and concern about neurodegenerative diseases continue to grow in an increasingly long-lived world population. Therefore, the search for new drugs continues to be a priority for medicinal chemistry. We present here the synthesis of a series of compounds with acetamide nuclei. Their structures were established using UV-Visible, NMR, HRMS and IR techniques. Furthermore, we report the crystal structures that were obtained from compounds 5a-5d by X-ray diffraction. The compounds were evaluated as potential inhibitors of the monoxidase enzymes; A (MAO-A) and B (MAO-B), and cholinesterases; acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) through in silico studies using the induced fit docking (IFD) method and binding free energy (ΔGbind) calculations by the MMGBSA method. Interestingly, compounds 5b, 5c and 5d showed much better ΔGbind than the reference drug Zonisamide. Compound 5c is the best in the series, which indicates a potential selective affinity of our compounds against MAO-B, which could be a promising finding in the search for new drugs for Parkinson's disease treatment. The acetamide crystal exhibits moderate NLO properties suggesting that it could be considered a potential candidate for application in nonlinear optical devices.
publishDate 2024
dc.date.issued.none.fl_str_mv 2024-02-09
dc.date.accessioned.none.fl_str_mv 2025-10-17T22:49:05Z
dc.date.available.none.fl_str_mv 2025-10-17T22:49:05Z
dc.type.none.fl_str_mv Artículo de revista
dc.type.coar.none.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coarversion.none.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.content.none.fl_str_mv Text
dc.type.driver.none.fl_str_mv info:eu-repo/semantics/article
dc.type.version.none.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_2df8fbb1
status_str publishedVersion
dc.identifier.citation.none.fl_str_mv Camargo-Ayala, L., Bedoya, M., Prent-Peñaloza, L., Polo-Cuadrado, E., Osorio, E., Brito, Iván., Delgado, G., González, W. y Gutierrez, M. (2024). Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes. RSC Advances, 14(8), 5222 - 5233. DOI: 10.1039/d3ra08649f
dc.identifier.doi.none.fl_str_mv 10.1039/d3ra08649f
dc.identifier.issn.none.fl_str_mv 20462069
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/20.500.12313/5800
dc.identifier.url.none.fl_str_mv https://pubs.rsc.org/en/content/articlelanding/2024/ra/d3ra08649f
identifier_str_mv Camargo-Ayala, L., Bedoya, M., Prent-Peñaloza, L., Polo-Cuadrado, E., Osorio, E., Brito, Iván., Delgado, G., González, W. y Gutierrez, M. (2024). Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes. RSC Advances, 14(8), 5222 - 5233. DOI: 10.1039/d3ra08649f
10.1039/d3ra08649f
20462069
url https://hdl.handle.net/20.500.12313/5800
https://pubs.rsc.org/en/content/articlelanding/2024/ra/d3ra08649f
dc.language.iso.none.fl_str_mv eng
language eng
dc.relation.citationendpage.none.fl_str_mv 5233
dc.relation.citationissue.none.fl_str_mv 8
dc.relation.citationstartpage.none.fl_str_mv 5222
dc.relation.citationvolume.none.fl_str_mv 14
dc.relation.ispartofjournal.none.fl_str_mv RSC Advances
dc.relation.references.none.fl_str_mv P. C. Poortvliet , K. O'Maley , P. A. Silburn and G. D. Mellick , Front. Neurol., 2020, 11 , 686
D. L. M. Radder , I. H. Sturkenboom , M. van Nimwegen , S. H. Keus , B. R. Bloem and N. M. de Vries , Int. J. Neurosci., 2017, 127 , 930 —943
J. P. M. Finberg and J. M. Rabey , Front. Pharmacol, 2016, 7 , 340
R. T. Bartus , R. L. Dean , B. Beer and A. S. Lippa , Science, 1982, 217 , 408 —417
W. Poewe , K. Seppi , C. M. Tanner , G. M. Halliday , P. Brundin , J. Volkmann , A. E. Schrag and A. E. Lang , Nat. Rev. Dis. Primers, 2017, 3 , 1 —21
V. A. Panova , S. I. Filimonov , Z. V. Chirkova , M. V. Kabanova , A. A. Shetnev , M. K. Korsakov , A. Petzer , J. P. Petzer and K. Y. Suponitsky , Bioorg. Chem., 2021, 108 , 104563
H. Wasan , D. Singh and R. KH , Brain Res. Bull., 2021, 168 , 165 —177
F. Stocchi , A. Antonini , D. Berg , B. Bergmans , W. Jost , R. Katzenschlager , J. Kulisevsky , P. Odin , F. Valldeoriola and K. Ray Chaudhuri , NPJ Parkinson's dis., 2022, 8 , 1 —9
D. Mishra , A. Fatima , P. Kumar , N. S. Munjal , B. K. Singh and R. Singh , ChemistrySelect, 2022, 7 , 202203060
S. Hosseini , S. A. Pourmousavi , M. Mahdavi and P. Taslimi , J. Mol. Struct., 2022, 1255 , 132229
L. Camargo-Ayala , L. Prent-Peñaloza , E. Polo-Cuadrado , I. Brito , J. Cisterna , E. Osorio , W. González and M. Gutiérrez , J. Mol. Struct., 2021, 131544
W.-H. Liu , L. Guan , D.-H. Zhao , Z.-W. He , Y.-M. Hu , Y.-X. Zhu , L.-J. Zhang , L.-H. Jin , L.-P. Guan and S.-H. Wang , SSRN Electron. J., 2022, 4149179
V. R. Pattabiraman and J. W. Bode , Nature, 2011, 480 , 471 —479
P. W. Seavill and J. D. Wilden , Green Chem., 2020, 22 , 7737 —7759
A. Williams and I. T. Ibrahim , Carbodiimide Chemistry: Recent Advances, 1981, 81 , 589 —636
J. R. Dunetz , J. Magano and G. A. Weisenburger , Org. Process Res. Dev., 2016, 20 , 140 —177
A. El-Faham and F. Albericio , Chem. Rev., 2011, 111 , 6557 —6602
A. Jordan , K. D. Whymark , J. Sydenham and H. F. Sneddon , Green Chem., 2021, 23 , 6405 —6413
L. A. Carpino and A. El-Faham , Tetrahedron, 1999, 55 , 6813 —6830
F. H. Allen , O. Kennard , D. G. Watson , L. Brammer , A. G. Orpen and R. Taylor , J. Chem. Soc., Perkin trans. 2, 1987, S1 —S19
J. Bernstein , R. E. Davis , L. Shimoni and N.-L. Chang , Angew. Chem., Int. Ed. Engl., 1995, 34 , 1555 —1573
B. Narayana , H. S. Yathirajan , R. Rathore and C. Glidewell , Acta Crystallogr., Sect. E: Crystallogr. Commun., 2016, 72 , 1270 —1275
S.-Y. Son , J. Ma , Y. Kondou , M. Yoshimura , E. Yamashita and T. Tsukihara , Proc. Natl. Acad. Sci. U. S. A., 2008, 105 , 5739 —5744
T. Rahman and M. Rahmatullah , Bioorg. Med. Chem. Lett., 2010, 20 , 537 —540
C. Binda , M. Aldeco , A. Mattevi and D. E. Edmondson , J. Med. Chem., 2011, 54 , 909 —912
F. Nachon , E. Carletti , C. Ronco , M. Trovaslet , Y. Nicolet , L. Jean and P. Y. Renard , Biochem. J., 2013, 453 , 393 —399
C. Ronco , R. Foucault , E. Gillon , P. Bohn , F. Nachon , L. Jean and P.-Y. Renard , ChemMedChem, 2011, 6 , 876 —888
M. Ahmed , J. B. T. Rocha , M. Corrêa , C. M. Mazzanti , R. F. Zanin , A. L. B. Morsch , V. M. Morsch and M. R. C. Schetinger , Chem.-Biol. Interact., 2006, 162 , 165 —171
I. Lukac , P. G. Wyatt , I. H. Gilbert and F. Zuccotto , J. Comput. Aided Mol. Des., 2021, 35 , 1025 —1036
Bruker AXS INC., APEX3, SAINT and SADABS, Bruker AXS Inc., Madison, Wisconsin, USA, 2016.
G. M.Sheldrick, SADABS, Software for Empirical Absorption Corrections, Univ. Göttingen, Göttingen, Germany, 2000.
O. V Dolomanov , L. J. Bourhis , R. J. Gildea , J. A. K. Howard and H. Puschmann , J. Appl. Crystallogr., 2009, 42 , 339 —341
G. M. Sheldrick Acta Crystallogr. C Struct. Chem., 2015, 71 , 3 —8
A. L. Spek J. Appl. Crystallogr., 2003, 36 , 7 —13
R. Krishnan , J. S. Binkley , R. Seeger and J. A. Pople , J. Chem. Phys., 1980, 72 , 650 —654
A. Hellweg and D. Rappoport , Phys. Chem. Chem. Phys., 2015, 17 , 1010 —1017
Y. Zhao and D. G. Truhlar , Theor. Chem. Acc., 2008, 120 , 215 —241
G. T.Frisch, H.Schlegel, G.Scuseria, M.Robb, J.Cheeseman, J.Montgomery, T.Vreven,K.Kudin, J.Burant, J.Millam, S.Iyengar, J.Tomasi, V.Barone, B.Mennucci, M.Cossi, G.Scalmani, N.Rega, G.Petersson, H.Nakatsuji, M.Hada, M.Ehara, K.Toyota, R.Fukuda, J.Hasegawa, M.Ishida, T.Nakajima, Y.Honda, O.Kitao, H.Nakai, M.Klene, X.Li, J.Knox, H.Hratchian, J.Cross, V.Bakken, C.Adamo, J.Jaramillo, R.Gomperts, R.Stratmann, O.Yazyev, A.Austin, R.Cammi, C.Pomelli, J.Ochterski, P.Ayala, K.Morokuma, G.Voth, P.Salvador, J.Dannenberg, V.Zakrzewski, S.Dapprich, A.Daniels, M.Strain, O.Farkas, D.Malick, A.Rabuck, K.Raghavachari, J.Foresman, J.Ortiz, Q.Cui, A.Baboul, S.Clifford, J.Cioslowski, B.Stefanov, G.Liu, A.Liashenko, P.Piskorz, I.Komaromi, R.Martin, D.Fox, T.Keith, A.Laham, C.Peng, A.Nanayakkara, M.Challacombe, P.Gill, B.Johnson, W.Chen, M.Wong, C.Gonzalez and J.Pople, Fox, Gaussian 09, Revision A.08, Gaussian, Inc., Wallingford, 2009.
R. Bauernschmitt and R. Ahlrichs , Chem. Phys. Lett., 1996, 256 , 454 —464
M. E. Casida , C. Jamorski , K. C. Casida and D. R. Salahub , J. Chem. Phys., 1998, 108 , 4439 —4449
S. Miertuš , E. Scrocco and J. Tomasi , Chem. Phys., 1981, 55 , 117 —129
J. L. Pascual-ahuir , E. Silla and I. Tuñon , J. Comput. Chem., 1994, 15 , 1127 —1138
H. Chermette J. Comput. Chem., 1999, 20 , 129 —154
Y.-Y. Hu , S.-L. Sun , S. Muhammad , H.-L. Xu and Z.-M. Su , J. Phys. Chem. C, 2010, 114 , 19792 —19798
H.-B. Zhao , Y.-Q. Qiu , C.-G. Liu , S.-L. Sun , Y. Liu and R.-S. Wang , J. Organomet. Chem., 2010, 695 , 2251 —2257
H. M. Berman Nucleic Acids Res., 2000, 28 , 235 —242
G. Madhavi Sastry , M. Adzhigirey , T. Day , R. Annabhimoju and W. Sherman , J. Comput. Aided Mol. Des., 2013, 27 , 221 —234
N. P. P. W. E.Schrödinger, LLC, New York, NY, Impact, Schrödinger, LLC, New York, NY, Prime, Schrödinger, LLC, New York, 2020.
M. H. M. Olsson , C. R. Søndergaard , M. Rostkowski and J. H. Jensen , J. Chem. Theory Comput., 2011, 7 , 525 —537
W. Sherman , T. Day , M. P. Jacobson , R. A. Friesner and R. Farid , J. Med. Chem., 2006, 49 , 534 —553
N. I. F. D. P. G.Schrödinger, LLC, New York, NY, Impact, Schrödinger, LLC, New York, NY, Prime, Schrödinger, LLC, New York, 2020.
dc.rights.eng.fl_str_mv © 2024 The Royal Society of Chemistry.
dc.rights.accessrights.none.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.none.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.license.none.fl_str_mv Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
dc.rights.uri.none.fl_str_mv https://creativecommons.org/licenses/by-nc/4.0/
rights_invalid_str_mv © 2024 The Royal Society of Chemistry.
http://purl.org/coar/access_right/c_abf2
Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)
https://creativecommons.org/licenses/by-nc/4.0/
eu_rights_str_mv openAccess
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Royal Society of Chemistry
dc.publisher.place.none.fl_str_mv Reino Unido
publisher.none.fl_str_mv Royal Society of Chemistry
institution Universidad de Ibagué
bitstream.url.fl_str_mv https://repositorio.unibague.edu.co/bitstreams/5d1959ae-1fc8-4ec5-ae53-18f963c04078/download
https://repositorio.unibague.edu.co/bitstreams/b04c7695-2a91-41b4-8965-2520a883c2f2/download
https://repositorio.unibague.edu.co/bitstreams/6811ad6e-0cbe-4935-bba7-6e6ca2c2c2f1/download
https://repositorio.unibague.edu.co/bitstreams/ed8e3d2d-03a1-4943-b37f-c341c1077d1f/download
bitstream.checksum.fl_str_mv 4e009ce9e71cabcd368304ebf1adfdf3
a93c7ad5acdf0d33c686e1eae0fa0eb8
c6354c13c54f5f640abb98ad62dcd08c
2fa3e590786b9c0f3ceba1b9656b7ac3
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional Universidad de Ibagué
repository.mail.fl_str_mv bdigital@metabiblioteca.com
_version_ 1851059990658285568
spelling Camargo-Ayala, Lorena41c900ab-b356-4c05-8594-1f10c2d6c414-1Bedoya, Mauricio0f2315c2-ea98-4abb-8701-a0488203a861-1Prent-Peñaloza, Luis75975bd9-cd4e-48b6-99cd-2cbb8f0b1dd9-1Polo-Cuadrado, Efraínf8016ac0-3f43-4599-89b2-3d8e129cb357-1Osorio Lopez, Edison Humbertoa28240e4-ba7f-4632-9175-08073951f7f5600Brito, Iván26ac473f-3c45-4d5a-9701-4e0cf4753fa9-1Delgado, Gerzon E.c9c0c137-e521-463a-aa0b-0f98d8785b6e-1González, Wendyfa2b8cdd-ad49-4bde-b134-d4509141f197-1Gutierrez, Margarita1e5d5269-2479-4110-89ea-da4a2fd1239f-12025-10-17T22:49:05Z2025-10-17T22:49:05Z2024-02-09The increase in and concern about neurodegenerative diseases continue to grow in an increasingly long-lived world population. Therefore, the search for new drugs continues to be a priority for medicinal chemistry. We present here the synthesis of a series of compounds with acetamide nuclei. Their structures were established using UV-Visible, NMR, HRMS and IR techniques. Furthermore, we report the crystal structures that were obtained from compounds 5a-5d by X-ray diffraction. The compounds were evaluated as potential inhibitors of the monoxidase enzymes; A (MAO-A) and B (MAO-B), and cholinesterases; acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) through in silico studies using the induced fit docking (IFD) method and binding free energy (ΔGbind) calculations by the MMGBSA method. Interestingly, compounds 5b, 5c and 5d showed much better ΔGbind than the reference drug Zonisamide. Compound 5c is the best in the series, which indicates a potential selective affinity of our compounds against MAO-B, which could be a promising finding in the search for new drugs for Parkinson's disease treatment. The acetamide crystal exhibits moderate NLO properties suggesting that it could be considered a potential candidate for application in nonlinear optical devices.application/pdfCamargo-Ayala, L., Bedoya, M., Prent-Peñaloza, L., Polo-Cuadrado, E., Osorio, E., Brito, Iván., Delgado, G., González, W. y Gutierrez, M. (2024). Crystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymes. RSC Advances, 14(8), 5222 - 5233. DOI: 10.1039/d3ra08649f10.1039/d3ra08649f20462069https://hdl.handle.net/20.500.12313/5800https://pubs.rsc.org/en/content/articlelanding/2024/ra/d3ra08649fengRoyal Society of ChemistryReino Unido52338522214RSC AdvancesP. C. Poortvliet , K. O'Maley , P. A. Silburn and G. D. Mellick , Front. Neurol., 2020, 11 , 686D. L. M. Radder , I. H. Sturkenboom , M. van Nimwegen , S. H. Keus , B. R. Bloem and N. M. de Vries , Int. J. Neurosci., 2017, 127 , 930 —943J. P. M. Finberg and J. M. Rabey , Front. Pharmacol, 2016, 7 , 340R. T. Bartus , R. L. Dean , B. Beer and A. S. Lippa , Science, 1982, 217 , 408 —417W. Poewe , K. Seppi , C. M. Tanner , G. M. Halliday , P. Brundin , J. Volkmann , A. E. Schrag and A. E. Lang , Nat. Rev. Dis. Primers, 2017, 3 , 1 —21V. A. Panova , S. I. Filimonov , Z. V. Chirkova , M. V. Kabanova , A. A. Shetnev , M. K. Korsakov , A. Petzer , J. P. Petzer and K. Y. Suponitsky , Bioorg. Chem., 2021, 108 , 104563H. Wasan , D. Singh and R. KH , Brain Res. Bull., 2021, 168 , 165 —177F. Stocchi , A. Antonini , D. Berg , B. Bergmans , W. Jost , R. Katzenschlager , J. Kulisevsky , P. Odin , F. Valldeoriola and K. Ray Chaudhuri , NPJ Parkinson's dis., 2022, 8 , 1 —9D. Mishra , A. Fatima , P. Kumar , N. S. Munjal , B. K. Singh and R. Singh , ChemistrySelect, 2022, 7 , 202203060S. Hosseini , S. A. Pourmousavi , M. Mahdavi and P. Taslimi , J. Mol. Struct., 2022, 1255 , 132229L. Camargo-Ayala , L. Prent-Peñaloza , E. Polo-Cuadrado , I. Brito , J. Cisterna , E. Osorio , W. González and M. Gutiérrez , J. Mol. Struct., 2021, 131544W.-H. Liu , L. Guan , D.-H. Zhao , Z.-W. He , Y.-M. Hu , Y.-X. Zhu , L.-J. Zhang , L.-H. Jin , L.-P. Guan and S.-H. Wang , SSRN Electron. J., 2022, 4149179V. R. Pattabiraman and J. W. Bode , Nature, 2011, 480 , 471 —479P. W. Seavill and J. D. Wilden , Green Chem., 2020, 22 , 7737 —7759A. Williams and I. T. Ibrahim , Carbodiimide Chemistry: Recent Advances, 1981, 81 , 589 —636J. R. Dunetz , J. Magano and G. A. Weisenburger , Org. Process Res. Dev., 2016, 20 , 140 —177A. El-Faham and F. Albericio , Chem. Rev., 2011, 111 , 6557 —6602A. Jordan , K. D. Whymark , J. Sydenham and H. F. Sneddon , Green Chem., 2021, 23 , 6405 —6413L. A. Carpino and A. El-Faham , Tetrahedron, 1999, 55 , 6813 —6830F. H. Allen , O. Kennard , D. G. Watson , L. Brammer , A. G. Orpen and R. Taylor , J. Chem. Soc., Perkin trans. 2, 1987, S1 —S19J. Bernstein , R. E. Davis , L. Shimoni and N.-L. Chang , Angew. Chem., Int. Ed. Engl., 1995, 34 , 1555 —1573B. Narayana , H. S. Yathirajan , R. Rathore and C. Glidewell , Acta Crystallogr., Sect. E: Crystallogr. Commun., 2016, 72 , 1270 —1275S.-Y. Son , J. Ma , Y. Kondou , M. Yoshimura , E. Yamashita and T. Tsukihara , Proc. Natl. Acad. Sci. U. S. A., 2008, 105 , 5739 —5744T. Rahman and M. Rahmatullah , Bioorg. Med. Chem. Lett., 2010, 20 , 537 —540C. Binda , M. Aldeco , A. Mattevi and D. E. Edmondson , J. Med. Chem., 2011, 54 , 909 —912F. Nachon , E. Carletti , C. Ronco , M. Trovaslet , Y. Nicolet , L. Jean and P. Y. Renard , Biochem. J., 2013, 453 , 393 —399C. Ronco , R. Foucault , E. Gillon , P. Bohn , F. Nachon , L. Jean and P.-Y. Renard , ChemMedChem, 2011, 6 , 876 —888M. Ahmed , J. B. T. Rocha , M. Corrêa , C. M. Mazzanti , R. F. Zanin , A. L. B. Morsch , V. M. Morsch and M. R. C. Schetinger , Chem.-Biol. Interact., 2006, 162 , 165 —171I. Lukac , P. G. Wyatt , I. H. Gilbert and F. Zuccotto , J. Comput. Aided Mol. Des., 2021, 35 , 1025 —1036Bruker AXS INC., APEX3, SAINT and SADABS, Bruker AXS Inc., Madison, Wisconsin, USA, 2016.G. M.Sheldrick, SADABS, Software for Empirical Absorption Corrections, Univ. Göttingen, Göttingen, Germany, 2000.O. V Dolomanov , L. J. Bourhis , R. J. Gildea , J. A. K. Howard and H. Puschmann , J. Appl. Crystallogr., 2009, 42 , 339 —341G. M. Sheldrick Acta Crystallogr. C Struct. Chem., 2015, 71 , 3 —8A. L. Spek J. Appl. Crystallogr., 2003, 36 , 7 —13R. Krishnan , J. S. Binkley , R. Seeger and J. A. Pople , J. Chem. Phys., 1980, 72 , 650 —654A. Hellweg and D. Rappoport , Phys. Chem. Chem. Phys., 2015, 17 , 1010 —1017Y. Zhao and D. G. Truhlar , Theor. Chem. Acc., 2008, 120 , 215 —241G. T.Frisch, H.Schlegel, G.Scuseria, M.Robb, J.Cheeseman, J.Montgomery, T.Vreven,K.Kudin, J.Burant, J.Millam, S.Iyengar, J.Tomasi, V.Barone, B.Mennucci, M.Cossi, G.Scalmani, N.Rega, G.Petersson, H.Nakatsuji, M.Hada, M.Ehara, K.Toyota, R.Fukuda, J.Hasegawa, M.Ishida, T.Nakajima, Y.Honda, O.Kitao, H.Nakai, M.Klene, X.Li, J.Knox, H.Hratchian, J.Cross, V.Bakken, C.Adamo, J.Jaramillo, R.Gomperts, R.Stratmann, O.Yazyev, A.Austin, R.Cammi, C.Pomelli, J.Ochterski, P.Ayala, K.Morokuma, G.Voth, P.Salvador, J.Dannenberg, V.Zakrzewski, S.Dapprich, A.Daniels, M.Strain, O.Farkas, D.Malick, A.Rabuck, K.Raghavachari, J.Foresman, J.Ortiz, Q.Cui, A.Baboul, S.Clifford, J.Cioslowski, B.Stefanov, G.Liu, A.Liashenko, P.Piskorz, I.Komaromi, R.Martin, D.Fox, T.Keith, A.Laham, C.Peng, A.Nanayakkara, M.Challacombe, P.Gill, B.Johnson, W.Chen, M.Wong, C.Gonzalez and J.Pople, Fox, Gaussian 09, Revision A.08, Gaussian, Inc., Wallingford, 2009.R. Bauernschmitt and R. Ahlrichs , Chem. Phys. Lett., 1996, 256 , 454 —464M. E. Casida , C. Jamorski , K. C. Casida and D. R. Salahub , J. Chem. Phys., 1998, 108 , 4439 —4449S. Miertuš , E. Scrocco and J. Tomasi , Chem. Phys., 1981, 55 , 117 —129J. L. Pascual-ahuir , E. Silla and I. Tuñon , J. Comput. Chem., 1994, 15 , 1127 —1138H. Chermette J. Comput. Chem., 1999, 20 , 129 —154Y.-Y. Hu , S.-L. Sun , S. Muhammad , H.-L. Xu and Z.-M. Su , J. Phys. Chem. C, 2010, 114 , 19792 —19798H.-B. Zhao , Y.-Q. Qiu , C.-G. Liu , S.-L. Sun , Y. Liu and R.-S. Wang , J. Organomet. Chem., 2010, 695 , 2251 —2257H. M. Berman Nucleic Acids Res., 2000, 28 , 235 —242G. Madhavi Sastry , M. Adzhigirey , T. Day , R. Annabhimoju and W. Sherman , J. Comput. Aided Mol. Des., 2013, 27 , 221 —234N. P. P. W. E.Schrödinger, LLC, New York, NY, Impact, Schrödinger, LLC, New York, NY, Prime, Schrödinger, LLC, New York, 2020.M. H. M. Olsson , C. R. Søndergaard , M. Rostkowski and J. H. Jensen , J. Chem. Theory Comput., 2011, 7 , 525 —537W. Sherman , T. Day , M. P. Jacobson , R. A. Friesner and R. Farid , J. Med. Chem., 2006, 49 , 534 —553N. I. F. D. P. G.Schrödinger, LLC, New York, NY, Impact, Schrödinger, LLC, New York, NY, Prime, Schrödinger, LLC, New York, 2020.© 2024 The Royal Society of Chemistry.info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Atribución-NoComercial 4.0 Internacional (CC BY-NC 4.0)https://creativecommons.org/licenses/by-nc/4.0/Estructura cristalinaBinding energyCrystal structureFree energyNeurodegenerative diseasesQuantum chemistryCrystal structure, quantum chemical insights, and molecular docking studies of Naryl-2-(N-disubstituted) acetamide compounds: potential inhibitors for neurodegenerative enzymesArtículo de revistahttp://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85Textinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionPublicationORIGINALArtículopdfArtículopdfapplication/pdf362415https://repositorio.unibague.edu.co/bitstreams/5d1959ae-1fc8-4ec5-ae53-18f963c04078/download4e009ce9e71cabcd368304ebf1adfdf3MD52TEXTArtículopdf.txtArtículopdf.txtExtracted texttext/plain5700https://repositorio.unibague.edu.co/bitstreams/b04c7695-2a91-41b4-8965-2520a883c2f2/downloada93c7ad5acdf0d33c686e1eae0fa0eb8MD53THUMBNAILArtículopdf.jpgArtículopdf.jpgIM Thumbnailimage/jpeg15931https://repositorio.unibague.edu.co/bitstreams/6811ad6e-0cbe-4935-bba7-6e6ca2c2c2f1/downloadc6354c13c54f5f640abb98ad62dcd08cMD54LICENSElicense.txtlicense.txttext/plain; charset=utf-8134https://repositorio.unibague.edu.co/bitstreams/ed8e3d2d-03a1-4943-b37f-c341c1077d1f/download2fa3e590786b9c0f3ceba1b9656b7ac3MD5120.500.12313/5800oai:repositorio.unibague.edu.co:20.500.12313/58002025-10-18 03:02:38.384https://creativecommons.org/licenses/by-nc/4.0/© 2024 The Royal Society of Chemistry.https://repositorio.unibague.edu.coRepositorio Institucional Universidad de Ibaguébdigital@metabiblioteca.comQ3JlYXRpdmUgQ29tbW9ucyBBdHRyaWJ1dGlvbi1Ob25Db21tZXJjaWFsLU5vRGVyaXZhdGl2ZXMgNC4wIEludGVybmF0aW9uYWwgTGljZW5zZQ0KaHR0cHM6Ly9jcmVhdGl2ZWNvbW1vbnMub3JnL2xpY2Vuc2VzL2J5LW5jLW5kLzQuMC8=